observation on the therapeutic effect of aspirin in combined with ozagrel sodium in the treatment of acute cerebral infarction

Clicks: 215
ID: 202142
2017
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Objective: To explore the clinical efficacy of aspirin in combined with ozagrel sodium in the treatment of acute cerebral infarction (ACI). Methods: A total of 120 patients with ACI who were admitted in our hospital from May, 2015 to May, 2016 were included in the study and randomized into the study group and the control group with 60 cases in each group. The patients in the two groups were given cerebral edema alleviating, brain cell protecting, cerebral circulation improving, and blood pressure controlling. The patients in the study group were given aspirin enteric-coated tablets, 0.1 g/time, 1 time/d. On the above basis, the patients in the study group were given ozagrel sodium (80 mg) + 0.9% NaCl (250 mL), ivdrip, 2 times/d. The patients in the two groups were treated for 14 d. The venous blood was extracted 1 d after admission and 14 d after treatment. The full automatic biochemical analyzer was used to detect PLT, PT, TT, FIB, and APTT. The radioimmunoassay was used to detect TXB2 and 6-K-PGF1α. The color Doppler ultrasound was used to detect IMT. Results: PLT, PT, TT, and APTT after treatment were not significantly different from those before treatment (P>0.05), but FIB was significantly reduced, and the reduced degree in the study group was significantly superior to that in the control group (P<0.05). After treatment, TXB2 level in the two groups was reduced, while 6-K-PGF1α was elevated, and those in the study group were significantly superior to those in the control group (P<0.05). After treatment, IMT in the two groups was reduced, and the reduced degree in the study group was significantly superior to that in the control group (P<0.05). Conclusions: Aspirin in combined with ozagrel sodium in the treatment of ACI can effectively inhibit the platelet aggregation, improve the coagulation function and cerebral blood supply, promote the recovery of cerebral nerve function after infarction, and enhance the therapeutic effect; therefore, it deserves to be widely recommended in the clinic.
Reference Key
2017journalobservation Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Hong-Jing Shen ;Hai-Yan He;Ming-Xuan Dai
Journal journal of communications
Year 2017
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.